CTSC and cancer: Ex vivo, inflammatory molecules released from cancer cells [e.g., IL‐8/CXCL8, granulocyte colony‐stimulating factor (G‐CSF), CXCL1, CXCL2, Cathepsin C, and Toll‐like receptor (TLR) ligands] can induce NETs.49